Elixir Energy passes the baton to a proven growth leader as it gears up to commercialise one of the East Coast’s largest undeveloped gas resources.
With all 92 stroke patients now treated, Argenica’s Phase 2 trial of ARG-007 heads into the critical data lock phase — and the biotech world is watching closely.
In a world-first clinical trial, Tryp Therapeutics is testing whether a psychedelic infusion can curb the compulsions of the most common eating disorder in the US.
Reach Resources has struck gold—literally and economically—with a shallow, high-grade deposit at Blue Heaven that could fast-track the junior to near-term production.
Zeus Resources may have just cracked open one of the world’s most compelling critical minerals plays, with antimony rock chips grading as high as 46.5% in the heart of Morocco.
Kingsland Minerals has delivered a high-grade Indicated Resource at Leliyn with near-perfect conversion from Inferred, setting the stage for a tightly focused graphite production strategy in the Northern Territory.
Leeuwin Metals is breathing new life into the Marda Gold Project, uncovering high-grade mineralisation overlooked by previous operators and unlocking fresh exploration potential across a historic goldfield
Elixir Energy has secured a cost-free pathway to near-term gas production by farming out its Diona sub-block to Xstate Resources, who will fully fund the upcoming exploration well.
White Cliff Minerals has launched an ambitious early-season drilling campaign at its Rae Copper Project in Canada’s Nunavut, with visible copper sulphides already intersected, positioning the company as a first mover in a historically rich but underexplored copper district.
Orthocell’s FDA clearance for its Remplir™ nerve repair device marks a major commercial milestone, unlocking access to the US$1.6 billion US market and positioning the Perth-based company for global growth and profitability.